ASX:SIL

Smiles Inclusive Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume54,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Smiles Inclusive (ASX:SIL) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying SIL stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Smiles Inclusive, including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

(BUX) (CNSX:BUX) and Smiles Inclusive (ASX:SIL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Analyst Ratings

This is a breakdown of current recommendations and price targets for (BUX) and Smiles Inclusive, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(BUX)0000N/A
Smiles Inclusive0000N/A

Valuation & Earnings

This table compares (BUX) and Smiles Inclusive's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(BUX)N/AN/AN/AN/AN/A
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A

(BUX) has higher earnings, but lower revenue than Smiles Inclusive.

Profitability

This table compares (BUX) and Smiles Inclusive's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(BUX)N/AN/AN/A
Smiles InclusiveN/AN/AN/A

Summary

Smiles Inclusive beats (BUX) on 1 of the 1 factors compared between the two stocks.

12144 (CNSX:IME) and Smiles Inclusive (ASX:SIL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, valuation, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for 12144 and Smiles Inclusive, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
121440000N/A
Smiles Inclusive0000N/A

Profitability

This table compares 12144 and Smiles Inclusive's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
12144N/AN/AN/A
Smiles InclusiveN/AN/AN/A

Valuation & Earnings

This table compares 12144 and Smiles Inclusive's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
12144N/AN/AN/AN/AN/A
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A

12144 has higher earnings, but lower revenue than Smiles Inclusive.

Summary

Smiles Inclusive beats 12144 on 1 of the 1 factors compared between the two stocks.

Smiles Inclusive (ASX:SIL) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent recommendations for Smiles Inclusive and BARD1 Life Sciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Smiles Inclusive0000N/A
BARD1 Life Sciences0000N/A

Valuation & Earnings

This table compares Smiles Inclusive and BARD1 Life Sciences' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A
BARD1 Life Sciences$612,251.000.00$-6,644,706.43A($0.08)N/A

BARD1 Life Sciences has lower revenue, but higher earnings than Smiles Inclusive.

Profitability

This table compares Smiles Inclusive and BARD1 Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Smiles InclusiveN/AN/AN/A
BARD1 Life SciencesN/AN/AN/A

Summary

BARD1 Life Sciences beats Smiles Inclusive on 2 of the 3 factors compared between the two stocks.

Smiles Inclusive (ASX:SIL) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Profitability

This table compares Smiles Inclusive and Charles River Laboratories International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Smiles InclusiveN/AN/AN/A
Charles River Laboratories InternationalN/AN/AN/A

Valuation & Earnings

This table compares Smiles Inclusive and Charles River Laboratories International's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A
Charles River Laboratories InternationalN/AN/AN/AN/AN/A

Charles River Laboratories International has lower revenue, but higher earnings than Smiles Inclusive.

Analyst Recommendations

This is a summary of current ratings for Smiles Inclusive and Charles River Laboratories International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Smiles Inclusive0000N/A
Charles River Laboratories International0000N/A

Summary

Smiles Inclusive beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Cryosite (ASX:CTE) and Smiles Inclusive (ASX:SIL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Analyst Ratings

This is a breakdown of current recommendations for Cryosite and Smiles Inclusive, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cryosite0000N/A
Smiles Inclusive0000N/A

Valuation & Earnings

This table compares Cryosite and Smiles Inclusive's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cryosite$9.71 million0.00$515,455.60A$0.01N/A
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A

Cryosite has higher earnings, but lower revenue than Smiles Inclusive.

Profitability

This table compares Cryosite and Smiles Inclusive's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CryositeN/AN/AN/A
Smiles InclusiveN/AN/AN/A

Summary

Cryosite beats Smiles Inclusive on 2 of the 3 factors compared between the two stocks.

dorsaVi (ASX:DVL) and Smiles Inclusive (ASX:SIL) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and price targets for dorsaVi and Smiles Inclusive, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
dorsaVi0000N/A
Smiles Inclusive0000N/A

Valuation and Earnings

This table compares dorsaVi and Smiles Inclusive's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
dorsaVi$1.65 million0.00$-3,158,396.93A($0.01)N/A
Smiles Inclusive$36.48 million0.00$-87,259,136.00A($0.55)N/A

dorsaVi has higher earnings, but lower revenue than Smiles Inclusive.

Profitability

This table compares dorsaVi and Smiles Inclusive's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
dorsaViN/AN/AN/A
Smiles InclusiveN/AN/AN/A

Summary

dorsaVi beats Smiles Inclusive on 2 of the 3 factors compared between the two stocks.


Smiles Inclusive Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
BD1
BARD1 Life Sciences
0.5N/AN/A$0.00$612,251.000.00High Trading Volume
Gap Up
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
CTE
Cryosite
0.6N/AN/A$0.00$9.71 million0.00High Trading Volume
Gap Up
DVL
dorsaVi
0.5N/AN/A$0.00$1.65 million0.00High Trading Volume
Gap Up
Epigenomics logo
EPGNY
Epigenomics
0.6$12.39flat$0.00N/A0.00News Coverage
ETAH
Eternity Healthcare
0.6$0.00flat$0.00N/A0.00
GSS
Genetic Signatures
0.0N/AN/A$0.00$29.13 million0.00High Trading Volume
GTG
Genetic Technologies
0.0N/AN/A$0.00$25,714.000.00High Trading Volume
IBX
Imagion Biosystems
0.6N/AN/A$0.00$2.70 million0.00High Trading Volume
News Coverage
Gap Up
IDX
Integral Diagnostics
0.8N/AN/A$0.00$314.82 million0.00High Trading Volume
Gap Up
LSH
Lifespot Health
0.5N/AN/A$0.00$22,127.000.00High Trading Volume
Gap Up
MEDD
Medical Imaging
0.4$0.01flat$0.00N/A0.00News Coverage
OSL
OncoSil Medical
0.5N/AN/A$0.00$2.22 million0.00High Trading Volume
Gap Up
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.01flat$0.00N/A0.00Gap Up
RHY
Rhythm Biosciences
0.0N/AN/A$0.00$1.21 million0.00High Trading Volume
Sartorius Aktiengesellschaft logo
SRT3
Sartorius Aktiengesellschaft
0.6$456.10flat$0.00N/A0.00High Trading Volume
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$29.24flat$0.00N/A0.00Gap Down
VHT
Volpara Health Technologies
0.5N/AN/A$0.00$15.22 million0.00High Trading Volume
Gap Up
OBJ
Wellfully Limited (OBJ.AX)
0.0N/AN/A$0.00$1.48 million0.00High Trading Volume
WUXIF
WuXi AppTec
1.0$19.88flat$0.00N/A0.00
This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.